Inotuzumab Ozogamicin
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 527 publications
Retrospective analysis of inotuzumab-associated hepatotoxicity in adult patients with B-cell acute lymphoblastic leukemia: Expanding the Spectrum of calicheamicin syndrome.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: April 10, 2026
Ph-Negative Acute Lymphoblastic Leukemia in the Older Adults: Biology, Therapeutic Strategies and Unmet Needs.
Journal: European journal of haematology
Published: February 06, 2026
Chemotherapy-Free Achievement of Minimal Residual Disease in a Jehovah's Witness Patient With Ph-Negative B-ALL.
Journal: The American journal of case reports
Published: January 31, 2026
Outcome of second-line therapy in adult B-cell acute lymphoblastic leukemia.
Journal: Cancer
Published: January 28, 2026
Brexu-cel cell therapy and subsequent allogeneic hematopoietic stem cell transplantation in the treatment of late-relapse B-cell acute lymphoblastic leukemia
Journal: Recenti progressi in medicina
Published: January 22, 2026
Efficacy and safety of inotuzumab ozogamicin as the definitive therapeutic option prior to allogeneic hematopoietic stem cell transplantation for pediatric relapsed/refractory B-cell acute lymphoblastic leukemia.
Journal: Leukemia & lymphoma
Published: January 07, 2026
Secondary Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia Following Prolonged Lenalidomide Maintenance in Multiple Myeloma.
Journal: Journal of medical cases
Published: December 17, 2025
Correction to "Real-World Data on Inotuzumab Ozogamicin for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A GRELAL-Chile Study".
Journal: Cancer medicine
Published: December 16, 2025
Outcomes of people living with acute lymphoblastic leukemia who received inotuzumab ozogamicin before a stem cell transplant: a plain language summary.
Journal: Future oncology (London, England)
Published: December 08, 2025
Inotuzumab ozogamicin-associated sinusoidal obstruction syndrome/veno-occlusive disease diagnosed by transjugular liver biopsy
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: December 07, 2025
Where do immunotherapies stand in management of acute leukemia in adults?
Journal: Hematology. American Society of Hematology. Education Program
Published: December 05, 2025
Revisiting novel genomic classifiers in the era of immunotherapy for pediatric B-ALL.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 05, 2025
Last Updated: 04/28/2026